INCELLART

In-Cell-Art is a biopharmaceutical company specializing in the preclinical and pharmaceutical development of nanocarriers named Nanotaxi® for macromolecular drugs... In-Cell-Art, is a biopharmaceutical company specializing in the preclinical and pharmaceutical development of solution (DNA/RNA based vaccines or therapeutics) treating acquired or inherited diseases using patented bioinspired synthetic delivery systems (named Nanotaxi®) consisting of different chemical families (lipids, polymers)... In-Cell-Art was founded in 2005 by a research team including Bruno Pitard and Jean-Marie Lehn (Nobel Laureate).

Primary location: Nantes France